ES71
TEAS SECTION 71 RECEIVED
07/30/2026
Back to search
Official data from USPTO
HEMOLUMI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMOLUMI
ST13
US500000079276710Class
5, 9, 10
Filing
79276710
Registration
6366592
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
07/30/2026
Trademark type
Word
Nice classes
5, 9, 10
Filing date
11/11/2019
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Guangdong, CN
Examiner
LAM, HAI-LY HUYNH
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representatives
Alex D. Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents for medical purposes; reagents for medical purposes; chemical preparations for medical purposesfor blood coagulation and anticoagulationfibrinolysis and anti-fibrinolysis functional analysisfor quantitative or qualitative detection of various analytes in human serumplasma or other body fluids; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical usedietetic sugar for medical usedietetic infusions for medical use; air purifying preparations; diagnostic reagents for veterinary purposes
Class 9
Computer programsrecordedfor controlling the operation of blood coagulation analyzing apparatus and instruments; computer operating programsrecorded; computer peripheral devices; recorded computer software for data analysis and processing; data processing equipmentcouplers; interfaces for computers; downloadable computer programs for monitoring data from medical imaging apparatus; downloadable electronic publicationsbookshand-outsworkbooks in the field of business; downloadable computer software applications for use in blood coagulation analyzing apparatus and instruments controlfor controlling mobile phonesportable media playershandheld computersfor remotely controlling other PC softwarefor database management and electronic storage of data; computer software applicationsdownloadablesoftware for use in database management and electronic storage of data
Class 10
Medical apparatus and instrumentsautomatic blood analyzers featuring a blood coagulation module and immunoassay module; diagnostic apparatus for medical purposesblood coagulation analyzing apparatus and instruments; blood testing apparatus; apparatus for blood analysis; testing apparatus for medical purposesblood testing apparatus; special containers especially adapted for the disposal of medical devicessyringes and other contaminated medical waste; containers especially made for medical waste; medical ultrasound equipment; suture materials; dental apparatus and instrumentsdental drillsdental picksdental excavators
Publications
History of USPTO decisions and trademark events.
43 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/22/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/22/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/22/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/01/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/29/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/17/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
09/17/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/16/2021
PUBO
PUBLISHED FOR OPPOSITION
03/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/14/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2021
ALIE
ASSIGNED TO LIE
02/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/06/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/19/2020
GNFR
FINAL REFUSAL E-MAILED
08/19/2020
CNFR
FINAL REFUSAL WRITTEN
08/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2020
RFNT
REFUSAL PROCESSED BY IB
03/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2020
RFRR
REFUSAL PROCESSED BY MPU
03/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/19/2020
CNRT
NON-FINAL ACTION WRITTEN
02/18/2020
DOCK
ASSIGNED TO EXAMINER
02/13/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/23/2020
Continuous trademark protection
Get notified about every new filing that threatens HEMOLUMI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.